11-4769272-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004752.2(OR51F1):āc.667A>Gā(p.Ile223Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004752.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR51F1 | NM_001004752.2 | c.667A>G | p.Ile223Val | missense_variant | 1/1 | ENST00000624103.2 | NP_001004752.2 | |
MMP26 | NM_021801.5 | c.-145+1931T>C | intron_variant | ENST00000380390.6 | NP_068573.2 | |||
MMP26 | NM_001384608.1 | c.-153+1931T>C | intron_variant | NP_001371537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR51F1 | ENST00000624103.2 | c.667A>G | p.Ile223Val | missense_variant | 1/1 | NM_001004752.2 | ENSP00000485387 | P1 | ||
MMP26 | ENST00000380390.6 | c.-145+1931T>C | intron_variant | 5 | NM_021801.5 | ENSP00000369753 | P1 | |||
MMP26 | ENST00000300762.2 | c.-153+1931T>C | intron_variant | 1 | ENSP00000300762 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461494Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727096
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.646A>G (p.I216V) alteration is located in exon 1 (coding exon 1) of the OR51F1 gene. This alteration results from a A to G substitution at nucleotide position 646, causing the isoleucine (I) at amino acid position 216 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at